Search clinical trials for: Asthmatic subjects

Total 21943 results

Guangdong Hengrui Pharmaceutical Co., Ltd

Not yet recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SHR-4597 Inhalation in Healthy Subjects and Asthmatic Patients

Healthy Subjects | Asthmatic Patients
Post Graduate Institute of Medical Education and...

Not yet recruiting

A RCT to Compare the Effectiveness of Nebulized Anticholinergics for Cough Suppression During Flexible Bronchoscopy (NAFCOF)

Subjects Undergoing Flexible Bronchoscopy

India
University of Colorado, Denver
United States Department of Defense

Recruiting

Advair HFA in Healthy and HAPE Predisposed Subjects (SWIFTARC)

Altitude Edema

United States
Wolfson Medical Center

Not yet recruiting

Combination of Diet and Oral Budesonide for Ulcerative Colitis (ReDUCE)

Ulcerative Colitis | Ulcerative Colitis Chronic Moderate | Ulcerative Colitis Chronic Mild

Israel, Switzerland, Italy, Netherlands
Commissariat A L'energie Atomique

Not yet recruiting

Evaluation of 3D Magnetic Resonance Spirometry : Comparison to Spirometry in Healthy Subjects and Patients With Asthma and COPD (gb-Spiro3D)

Asthma | COPD

France
Massachusetts General Hospital

Recruiting

Methemoglobin Concentration in High Dose Inhaled Nitric Oxide

Healthy Subjects

United States
Monash Medical Centre

Recruiting

Vocal Cord Responses During Hyperventilation in Normal Individuals and in Mild and Severe Asthmatics.

Asthma | Hyperventilation | Larynx

Australia
Yuhan Corporation

Recruiting

A Multiple Ascending Dose, Phase 1b Study of YH35324 in Atopic Healthy Subjects or Subjects With Mild Allergic Diseases

Atopic Healthy Subjects | Adult Subjects With Mild Allergic Diseases

Korea, Republic of
Kashiv BioSciences, LLC

Recruiting

PK, PD, Safety & Immunogenicity of ADL-018 Lyo in Healthy Adult Subjects

Healthy

India
Lipidor AB

Recruiting

A Phase III Study in Subjects With Mild to Moderate Psoriasis. (AKVANO-AKP02)

Mild to Moderate Psoriasis

India
Bazell Pharma AG

Not yet recruiting

Pharmacokinetics, Efficacy, Tolerability and Safety of Different Budesonide Oral Gel Doses in Adults' Subjects of Both Genders With Eosinophilic Esophagitis (EoE) (BESIDE)

Eosinophilic Esophagitis
Chiesi Farmaceutici S.p.A.

Recruiting

A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD (TRITON)

COPD | COPD Exacerbation

United States, Bulgaria, Hungary, Poland, Argentina, Czechia, Mexico, Canada, Puerto Rico, Romania
Bausch Health Americas, Inc.

Recruiting

Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis

Ulcerative Colitis

United States
Organon and Co

Completed

Study of Inhaled Glucocorticosteroids/Long-Acting Bronchodilator Drugs in Subjects With Asthma That Have Been Taking Inhaled Glucocorticosteroids (Study P04705AM1)

Asthma
Organon and Co
Novartis

Completed

A Patient Handling Study of Mometasone Furoate/Formortoral Fumarate (MF/F) Metered Dose Inhaler (MDI) With an Integrated Dose Counter in Adolescent and Adult Subjects With Asthma or Chronic Obstructive Pulmonary Disease (Study P04703AM1)

Asthma | COPD
Organon and Co

Completed

Pediatric ACTION3 (Identify, Treat, Control): Effectiveness of Adding Montelukast in Pediatric Subjects With Uncontrolled Asthma (0476-385)

Asthma
Organon and Co

Completed

The Singulair® add-on Study Effectiveness of Adding Montelukast to Inhaled Corticosteroids in Adult Subjects With Uncontrolled Asthma (0476-384) (SAS)

Asthma
Ellodi Pharmaceuticals, LP

Active, not recruiting

24-Week Induction Study of APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE 3) (FLUTE-3)

Eosinophilic Esophagitis

United States, Canada
Food and Drug Administration (FDA)
Spaulding Clinical Research LLC

Completed

Pharmacodynamic Biomarkers to Support Biosimilar Development: Interleukin-5 Antagonists

Healthy Subjects | Pharmacokinetics | Pharmacodynamics

United States
Primus Pharmaceuticals
Prosoft Clinical

Completed

Patient Satisfaction Following Twice Daily Dosing With DFD-01 in Subjects With Moderate Plaque Psoriasis

Plaque Psoriasis

United States
Third Pole Therapeutics, Inc.

Active, not recruiting

Early Feasibility Study Evaluating the 3P-100 Device in Subjects With PH-ILD (EFS)

Hypertension, Pulmonary | Lung Diseases, Interstitial

United States
ARS Pharmaceuticals, Inc.

Active, not recruiting

Administration of ARS-1 or Albuterol in Subjects With Persistent Asthma

Asthma

United States
GlaxoSmithKline

Completed

Effects of a Orally Inhaled Fluticasone Furoate on Growth Velocity in Prepubertal, Paediatric Subjects With Asthma Over a Year

Asthma

Argentina, Russian Federation, United States, South Africa, Poland, Romania
Istituti Clinici Scientifici Maugeri SpA

Completed

Evaluation of Physical Activity in Asthmatic Subjects

Physical Activity | Asthma

Italy
Surface Ophthalmics, Inc.

Completed

Research Study To See How Well An Eye Drop (SURF-200) Works, What Side Effects There Are, And To Compare It With Vehicle In Subjects With An Episodic Flare-Up of Dry Eye Disease

Dry Eye Disease

United States
Ellodi Pharmaceuticals, LP

Completed

Efficacy and Safety APT-1011 in Adolescent Subjects With Eosinophilic Esophagitis (EoE) - A Sub-Study of the FLUTE-2 Trial (FLUTEEN)

Eosinophilic Esophagitis

Australia, United States
Kashiv BioSciences, LLC

Completed

To Compare the PK, PD, Safety & Immunogenicity of ADL-018 in Healthy Subjects

Healthy

India
GlaxoSmithKline

Completed

MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects

Asthma

United States, Argentina, Australia, France, Germany, Poland, Romania, Russian Federation, Canada, Chile, Korea, Republic of, Ukraine, United Kingdom
Jemincare

Completed

Study of JYB1904 (an Anti-immunoglobulin E Antibody) in Healthy Chinese Subjects

Healthy

China
Ellodi Pharmaceuticals, LP

Completed

Efficacy and Safety APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2) (FLUTE-2)

Eosinophilic Esophagitis

United States, Australia, Spain
Taizhou Mabtech Pharmaceutical Co.,Ltd

Completed

The Study of Omalizumab (CMAB007 and Xolair) in Healthy Subjects to Compare the PK, PD, Safety and Immunogenicity

Healthy Volunteers

China
Vastra Gotaland Region

Enrolling by invitation

Changes of Motor Function Tests in Congenital Myopathy Subjects Treated With Oral Salbutamol as Compared to no Treatment (COMPIS)

Musculoskeletal Diseases | Neuromuscular Diseases | Centronuclear Myopathy | Nemaline Myopathy | Congenital Myopathy | Myosin Storage Myopathy

Sweden
AstraZeneca
Parexel

Completed

A Study to Assess the Total Systemic Exposure Bioequivalence of of Budesonide, Glycopyrronium, and Formoterol Delivered by BGF MDI HFO Compared With BGF MDI HFA

Chronic Obstructive Pulmonary Disease

United States
Celltrion

Completed

To Compare the PK and Safety of Omalizumab (CT-P39, EU-approved Xolair, and US-licensed Xolair) in Healthy Subjects

Healthy

Australia
AstraZeneca
Parexel

Completed

Study to Assess the Lung Exposure Bioequivalence of Budesonide, Glycopyrronium, and Formoterol Delivered by BGF MDI HFO Compared With BGF MDI HFA

Chronic Obstructive Pulmonary Disease

United States
Adare Pharmaceuticals, Inc.

Completed

Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) (FLUTE)

Eosinophilic Esophagitis

Spain, United States, Belgium, Switzerland, Germany, Canada
Fraunhofer-Institute of Toxicology and Experimental...
Boehringer Ingelheim

Completed

Effects of Spiolto® Respimat® (Tiotropium/Olodaterol) on Cardiac Function in Hyperinflated COPD Subjects

Chronic Obstructive Pulmonary Disease

Germany
Imperial College London
National Institute for Health Research, United Kingdom

Completed

Inhaler Lung Deposition in Chronic Obstructive Pulmonary Disease (COPD)

ASTHMA | CHRONIC OBSTRUCTIVE PULMONARY DISEASE | HEALTHY SUBJECTS

United Kingdom
Bellerophon Pulse Technologies
Worldwide Clinical Trials

Terminated

Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH (INOvation-1)

Pulmonary Arterial Hypertension

United States, Australia, Canada, Israel, Netherlands, Serbia, Spain, United Kingdom, Croatia, Portugal, Germany, Austria, Belgium, Colombia, Czechia, France, Italy, Ukraine
Bellerophon Pulse Technologies
Worldwide Clinical Trials

Withdrawn

Study of PAH Subjects With LTOT Use That Have Demonstrated Improved Exercise Tolerance With the Use of Inhaled Nitric

Pulmonary Arterial Hypertension

United States, Canada
Bellerophon

Terminated

Effect iNO on Functional Respiratory Imaging in Subjects With WHO Group 3 Pulmonary Hypertension With COPD on Oxygen

Chronic Obstructive Pulmonary Disease | Pulmonary Hypertension | COPD

Belgium
University of California, San Francisco

Suspended

Characterization of Adult Subjects for Asthmatic Research Studies (CASA)

Asthma

United States
Surface Pharmaceuticals, Inc.

Completed

A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease

Dry Eye Disease

United States
Yuhan Corporation

Completed

A FIH Study of YH35324 in Atopic Healthy Subjects or Subjects With Mild Allergic Diseases

Atopic Healthy Subjects | Adult Subjects With Mild Allergic Diseases

Korea, Republic of
Acasti Pharma Inc.

Active, not recruiting

Comparative Bioavailability of Betamethasone Oral Solution Metered Spray (GTX-102) in Healthy Subjects

Ataxia Telangiectasia

Canada
GlaxoSmithKline

Completed

A Safety and Efficacy Study of Mepolizumab in Subjects With Severe Asthma

Asthma

China
Andover Research Eye Institute

Completed

A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Flonase® Allergy Relief in Subjects With Allergic Conjunctivitis

Allergic Conjunctivitis

United States
Abbott

Completed

Bio-Equivalence Study of Budesonide Prolonged-release Tablets 9 Mg In Healthy Human Adult Subjects

Healthy Subjects | Healthy Participants | Bioequivalence | Human Volunteers

India
ARS Pharmaceuticals, Inc.

Completed

Pharmacokinetics of Adrenaline After Administration of ARS -1 in Subjects With Upper Respiratory Tract Infection

Upper Respiratory Tract Infection

Australia
Sandoz

Completed

In Vivo Performance of Oral Liquid Formulations of Budesonide in the Fasted State in Healthy Subjects

Healthy Volunteers

United Kingdom

3

Subscribe